An integrated pharmacokinetics ontology and corpus for text mining

BMC Bioinformatics

Volumn 14, Issue 1, 2013, Pages

  Wu, Heng Yi ^a   Karnik, Shreyas ^a   Subhadarshini, Abhinita ^a   Wang, Zhiping ^a   Philips, Santosh ^a   Han, Xu ^a   Chiang, Chienwei ^a   Liu, Lei ^b   Boustani, Malaz ^c   Rocha, Luis M ^d   Quinney, Sara K ^a   Flockhart, David ^a,e   Li, Lang ^a,d  

^a INDIANA UNIVERSITY   (United States)

^b SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^c REGENSTRIEF INSTITUTE   (United States)

^d Indiana University   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNOTATION SCHEME; DATA COLLECTION; DRUG METABOLISMS; IN-VITRO; IN-VIVO; INTERACTION EXTRACTION; INTERACTION PARAMETERS; INTERACTION STUDIES; PHARMACOKINETICS PARAMETERS; TEXT MINING;

DATA MINING; DRUG INTERACTIONS; EXPERIMENTS;

PHARMACOKINETICS;

CYTOCHROME P450; KETOCONAZOLE; MIDAZOLAM; TAMOXIFEN;

ARTICLE; DATA MINING; DRUG INTERACTION; FACTUAL DATABASE; GENETICS; METHODOLOGY; PHARMACOKINETICS;

CYTOCHROME P-450 ENZYME SYSTEM; DATA MINING; DATABASES, FACTUAL; DRUG INTERACTIONS; KETOCONAZOLE; MIDAZOLAM; PHARMACOKINETICS; TAMOXIFEN;

EID: 84873033718     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-14-35     Document Type: Article

References (21)

1. Rowland M, Tozer TN. Clinical pharmacokinetics concept and applications 1995, London: Lippincott Williams & Wilkins.
2. Segura-Bedmar I, Martínez P, de Pablo-Sánchez C. Using a shallow linguistic kernel for drug-drug interaction extraction. J Biomed Inform 2011, 44(5):789-804. 10.1016/j.jbi.2011.04.005, 21545845.
3. Tari L, Anwar S, Liang S, Cai J, Baral C. Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics 2010, 26(18):i547-i553. 10.1093/bioinformatics/btq382, 2935409, 20823320.
4. Wang Z, Kim S, et al. Literature mining on pharmacokinetics numerical data: a feasibility study. J Biomed Inform 2009, 42(4):726-735. 10.1016/j.jbi.2009.03.010, 2737819, 19345282.
5. Segel HI. Enzyme kinetics - behavior and analysis of rapid equilibrium and steady state enzyme systems 1975, New York: John Wiley & Sons, Inc.
6. Giacomini KM. Membrane transporters in drug development. Nat Rev Drug Discov 2010, 9(3):215-36. 10.1038/nrd3028, 3326076, 20190787.
7. Rostami-Hodjegan A, Tucker G. " In silico" simulations to assess the " in vivo" consequences of " in vitro" metabolic drug-drug interactions. Drug Discovery Today: Technologies 2004, 1:441-448.
8. Gibaldi M, Perrier D. Pharmacokinetics 1982, New York: Marcel Dekker, 2.
9. Huang SM, et al. Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther 2007, 81(2):298-304. 10.1038/sj.clpt.6100054, 17259955.
10. Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol 2008, 21(1):70-83. 10.1021/tx700079z, 18052394.
11. Knox C, et al. Drugbank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011, 39(Database issue):D1035-D1041. 3013709, 21059682.
12. Rubin DL, Noy NF, Musen MA. Protege: a tool for managing and using terminology in radiology applications. J Digit Imaging 2007, 20(Suppl 1):34-46. 2039856,2039856, 17687607.
13. Brunton LL, Chabner BA, Knollmann BC. Goodman & Gilman's The Pharmacological Basis Of Therapeutics. 12. New York: McGraw-Hill.
14. Krippendorff K. Content analysis: an introduction to its methodology 2004, Thousand Oaks, CA: SAGE Publications Inc.
15. Kim JD, et al. Genia corpus-a semantically annotated corpus for bio-textmining. Bioinformatics 2003, 19(Supp 1):i180-2.
16. Borges S, et al. Composite functional genetic and comedication cyp2d6 activity score in predicting tamoxifen drug exposure among breast cancer patients. J Clin Pharmacol 2010, 50(4):450-458. 10.1177/0091270009359182, 20081063.
17. Chien JY, et al. Stochastic prediction of cyp3a-mediated inhibition of midazolam clearance by ketoconazole. Drug Metab Dispos 2006, 34(7):1208-1219. 10.1124/dmd.105.008730, 16611859.
18. Williams JA, et al. Comparative metabolic capabilities of cyp3a4, cyp3a5, and cyp3a7. Drug Metab Dispos 2002, 30(8):883-91. 10.1124/dmd.30.8.883, 12124305.
19. Airola A, et al. All- paths graph kernel for protein-protein interaction extraction with evaluation of cross-corpus learning. BMC Bioinforma 2008, 9(Suppl 11):S2.
20. De Marneffe M, MacCartney B, Manning C. Generating typed dependency parses from phrase structure parses. Proceedings of LREC 2006, 6:449-454.
21. Karnik S, et al. Extraction of drug-drug interactions using all paths graph kernel, in 1st Challenge task on Drug Drug Interaction Extraction 2011, Spain: Huelva.